EVEXIA LIFECARE LIMITED

Chemicals · Chemicals & Petrochemicals

BSE: 524444
₹1.92
▲ 0.04 (2.13%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
58/100
Moderate
Valuation
—/100
Data unavailable
Momentum
71/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-45.4
Free Cash Flow
₹-27 Cr
as of March 31, 2026
Industry median ₹-0 Cr (238 companies)
EPS Growth (YoY)
-100.00%
as of Dec. 31, 2025
Industry median 39.08% (220 companies)
Net Profit Growth (TTM)
-4.49%
as of June 30, 2026
Industry median 13.45% (212 companies)
Operating Revenue Growth (TTM)
28.09%
as of June 30, 2026
Industry median 7.93% (209 companies)
Profit Growth (YoY)
-29.30%
as of June 30, 2026
Industry median 23.11% (213 companies)
Revenue Growth (YoY)
43.57%
as of June 30, 2026
Industry median 17.49% (205 companies)
Current Ratio
1.50
as of March 31, 2026
Industry median 1.87 (237 companies)
Debt to Equity
0.01
as of March 31, 2026
Industry median 0.16 (224 companies)
Interest Coverage
430.39
as of June 30, 2026
Industry median 8.97 (221 companies)
Net Margin
1.40%
as of June 30, 2026
Industry median 7.49% (212 companies)
Operating Margin (EBIT)
1.90%
as of June 30, 2026
Industry median 11.88% (214 companies)
Operating Margin (TTM)
1.84%
as of June 30, 2026
Industry median 9.75% (219 companies)
Return on Assets
0.18%
as of March 31, 2026
Industry median 4.33% (217 companies)
Return on Capital Employed
0.29%
as of March 31, 2026
Industry median 10.34% (218 companies)
Return on Equity
0.36%
as of March 31, 2026
Industry median 7.52% (219 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.01)
  • No Return on equity is 15% or more (0.4%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 4 met
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
2.1%
Low 1.8600 · High 1.9600
1W return
2.7%
Low 1.8300 · High 1.9600
1M return
31.5%
Low 1.2400 · High 1.9600
52W return
-47.5%
Low 1.2400 · High 1.9600
Lifetime High ₹165.0000 (Jan. 19, 2021)
Lifetime Low ₹1.2800 (Sept. 3, 2026)

Full price history and technicals →

EMA & SMA

Bullish4
Bearish2
5D
1.9
10D
1.8
20D
1.7
50D
1.8
100D
1.9
200D
2.1

Delivery and volume

Day avg. delivery
61.5%
Week avg. delivery
66.4%
Month avg. delivery
80.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1.91
Pivot
First resistance1.97
Second resistance2.01
Third resistance2.07
First support1.87
Second support1.81
Third support1.77
Day RSI63.6
Day MFI65.1
Day MACD0.08
Day MACD signal0.04

Beta

1M-0.50
3M-0.58
1Y-0.58
3Y0.25

Price change analysis

↑ 31.5%
Over 1 Month
LowHigh
1.241.96
↓ -47.5%
Over 3 Months
LowHigh
1.241.96
↓ -47.5%
Over 6 Months
LowHigh
1.241.96
↓ -47.5%
Over 1 Year
LowHigh
1.241.96
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹30 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.0000

Ranks #None of 221 in Chemicals & Petrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter3.36%
  • Mutual funds0.02%
  • Other DII0.08%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 3.36% in Jun 2026 qtr

Historical fii holding

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.02% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
17 Sep 2026 MANSI SHARE AND STOCK BROKING PRIVATE LIMITED Bulk Sell 2,500,000 1.7800 BSE
17 Sep 2026 MANSI SHARE AND STOCK BROKING PRIVATE LIMITED Bulk Buy 9,877,026 1.6900 BSE
16 Sep 2026 PRIJAL TRADEFIN LLP Bulk Buy 1,850,000 1.7100 BSE
16 Sep 2026 F3 ADVISORS PRIVATE LIMITED Bulk Buy 2,570,192 1.7900 BSE
16 Sep 2026 F3 ADVISORS PRIVATE LIMITED Bulk Sell 9,845,192 1.7700 BSE
16 Sep 2026 PRIJAL TRADEFIN LLP Bulk Sell 10,315,400 1.7400 BSE
16 Sep 2026 MANSI SHARE AND STOCK BROKING PRIVATE LIMITED Bulk Buy 11,200,000 1.7500 BSE
16 Sep 2026 SHREE SAIBABA EXIM PRIVATE LIMITED Bulk Buy 29,356,550 1.7800 BSE
8 Sep 2026 SHREE SAIBABA EXIM PRIVATE LIMITED Bulk Buy 38,269,858 1.4400 BSE
4 Sep 2026 NEO APEX SHARE BROKING SERVICES LLP Bulk Sell 5 1.2800 BSE

All bulk and block deals →

Corporate Actions

Full history (3 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from ATREYA PETROCHEM LTD. to Kavit Industries Limited
—NAME_CHANGEName changed from JAL HI POWER PETROCHEM LTD. to Atreya Petrochem Ltd
—NAME_CHANGEName changed from Kavit Industries Limited to EVEXIA LIFECARE LIMITED

All corporate actions →

Corporate Announcements

All 21 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Company Update Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
30 Sep 2026 AGM/EGM Evexia Lifecare Ltd - 524444 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Insider Trading / SAST Evexia Lifecare Ltd - 524444 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
29 Sep 2026 Company Update Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
28 Sep 2026 Insider Trading / SAST Evexia Lifecare Ltd - 524444 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
28 Sep 2026 Company Update Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
25 Sep 2026 Insider Trading / SAST Evexia Lifecare Ltd - 524444 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
25 Sep 2026 Company Update Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
19 Sep 2026 Insider Trading / SAST Evexia Lifecare Ltd - 524444 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
18 Sep 2026 Company Update Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.01)
  • Comfortable interest coverage (430.4x)
  • Healthy liquidity (Current Ratio 1.50)
  • Strong revenue growth YoY (43.6%)

Weaknesses

  • Low Return on Equity (0.4%)
  • Thin net profit margin (1.4%)
  • Declining profit YoY (-29.3%)

Opportunities

Data unavailable.

Threats

  • Down 47.5% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about EVEXIA LIFECARE LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.